Skip to main content

Table 1 The expression of PEG10 in cancer patients and cancer cell lines

From: PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression

Tumors

Type

Methods

Expression

References

HCC

Primary HCC

IHC

15/16a

[9]

HCC tissues and cell lines

cDNA microarray

Significantly higher

[16]

HCC cell lines

QPCR

18/20b

[17]

Primary HCC

QPCR

Significantly higher

HCC tissues

IHC

148/218a

[19]

Pancreatic carcinoma

Pancreatic carcinoma tissues

IHC

85/160b

[20]

Breast cancer

Ductal carcinoma

IHC

6/11a

[10]

Invasive ductal carcinomas

IHC

7/22a

Breast cancer tissue (n = 161)

IHC

36%a

Prostate cancer

Prostate cancer tissue (n = 30)

IHC

37%a

[10]

Gallbladder carcinoma

Gallbladder adenocarcinoma tissues

IHC

52/108a

[21]

Thyroid cancer

24 thyroid cancer tissues and 14 normal thyroid tissues

QPCR

Significantly higher (P = 0.034)

[22]

OSCC

OSCC tissues

QPCR

83/118b

[23]

Colon cancer

Colon cancer tissues

QPCR and WB

9/20a

[24]

Enchondromas

Enchondromas tissues

IHC and QPCR

Strongly positive expression

[25]

B-CLL

B-CLL PBMNCs

QPCR

40/42b

[26]

  1. IHC immunohistochemistry, QPCR quantitative polymerase chain reaction, OSCC oral squamous cell carcinoma, WB western blot, PBMNC peripheral blood mononuclear cell
  2. aProportion of PEG10-positive tumor tissues/cells
  3. bProportion of tumor tissues/cells occurred PEG10 upregulation compared to normal tissues/cells